× Metabolic syndrome in parathyroid diseases

× Normal alkaline phosphatase level in a patient with primary hyperparathyroidism due to parathyroid adenoma

× Perspectives on the relationship of urolithiatic markers and primary hyperparathyroidism

× Association of parathyroid hormone with plasma magnesium in health and disease; a review

× Hyperparathyroidism and vessel diseases

× Maxillofacial radiographic changes in renal osteodystrophy

× Estimation of annual per capita treatment in osteoporosis

× Intraoperative parathyroid hormone monitoring in primary hyperparathyroidism; resolving controversies and debates

× Pulmonary hypertension and deficiency of vitamin D

× Parathyroid hormone level predicts mortality in hemodialysis; an old problem remains still

× Secondary hyperparathyroidism in chronic hemodialysis patients in Khuzestan province, Iran

× Cinacalcet in patients with primary hyperparathyroidism; a review

× Possible renoprotection impact of cinacalcet; a review on current studies

× Parathyroid carcinoma; an updated mini-review on current trends

× Hypercalcemia and hyperparathyroidism in long-term lithium administration

× Relationship of circulating levels of 25(OH) vitamin D with parathyroid hormone in Iranian patients with chronic kidney disease not yet on dialysis; what is the best threshold for 25(OH) vitamin D

× Cardiac effects of parathyroid hormone excess; an updated mini-review

× Excessive production of parathyroid hormone in association with left ventricular dysfunction in regular hemodialysis patients

× The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

× Serum magnesium in association with parathyroid hormone levels in routine hemodialysis patients

× Parathyroid disease; a bridge between nephrologist and endocrinologist

× Parathyroidectomy for children with chronic renal failure and secondary hyperparathyroidism; what is the best technique?

× Bone mineral density and bone metabolism biochemical markers in patients with chronic kidney disease at the hemodialysis treatment

× Magnesium and parathyroid hormone among end-stage renal disease patients

× Cinacalcet therapy for achievement of the NKF/K-DOQITM clinical practice guidelines for bone and mineral metabolism in individuals under regular hemodialysis

× Cinacalcet in patients with secondary hyperparathyroidism; a review

× Secondary hyperparathyroidism among end-stage renal disease patients in Beharlou hospital, Tehran province, Iran

× Diseases of the parathyroid glands in chronic kidney disease

× Future prospects in parathyroid diseases

× Interactions of vitamin D with parathyroid glands; an updated mini-review

× Effect of industrial cadmium contamination on parathyroid hormone secretion; a new look at an old problem

× Sclerostin in hemodialysis patients

× Possible cancer enhancement impact of parathyroid hormone excess

× Mechanistic impact of fibrosis by parathyroid hormone excess

× Impact of parathyroid hormone on osteoporosis; a short look at the current knowledge

× Relationship between Klotho and parathormone

× Normocalcemic primary hyperparathyroidism; a mini-review

× Recent advancements in the treatment of tertiary hyperparathyroidism